The tyrosine phosphatase inhibitor vanadate protects osteoblasts from growth inhibition by glucocorticoids.

The tyrosine phosphatase inhibitor vanadate protects osteoblasts from growth inhibition by glucocorticoids.

Bibliografski detalji
Glavni autori:	Hulley, P, Conradie, R, Titus, C, Hough, F
Format:	Journal article
Izdano:	1999

Slični predmeti

Vanadate protects osteoblasts in vitro and in vivo from glucocorticoid impairment of proliferation
od: Hulley, P, i dr.
Izdano: (2002)

Pathogenesis of glucocorticoid osteoporosis: Role of tyrosine phosphatases
od: Hulley, P, i dr.
Izdano: (2001)

Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo.
od: Conradie, M, i dr.
Izdano: (2007)

Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate.
od: Hulley, P, i dr.
Izdano: (2002)

Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
od: Horsch, K, i dr.
Izdano: (2007)

Glucocorticoids inhibit osteoblast proliferation via transcriptional upregulation of MKP-1: A prime target for the development of novel osteo-anabolic agents
od: Hulley, P, i dr.
Izdano: (2003)

Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases.
od: Hulley, P, i dr.
Izdano: (1998)

Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines.
od: Engelbrecht, Y, i dr.
Izdano: (2003)

Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.
od: Espina, B, i dr.
Izdano: (2008)

BIM is a novel regulator of glucocorticoid-induced apoptosis in osteoblasts
od: Espina, B, i dr.
Izdano: (2006)

MECHANISMS OF OSTEOBLAST INHIBITION BY STEROIDS
od: Hulley, P
Izdano: (2004)

Rapid inhibitory effects of glucocorticoids on ERK activity and osteoblast proliferation occur via transcriptional upregulation of MKP-1
od: Horsch, K, i dr.
Izdano: (2004)

Regulation of tyrosine phosphorylation cascades by phosphatases: What the actions of vanadium teach us
od: Hulley, P, i dr.
Izdano: (2003)

Rapid inhibitory effects of glucocorticoids on ERK activity and osteoblast proliferation occur via transcriptional upregulation of MKP-1
od: Horsch, K, i dr.
Izdano: (2004)

Alternative insulin signalling pathways in osteoblasts
od: Langeveldt, C, i dr.
Izdano: (2002)

Bim as a potential target in osteoblast survival
od: Espina, B, i dr.
Izdano: (2005)

Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases
od: Wiljan Hendriks, i dr.
Izdano: (2018-02-01)

Alternative insulin signalling pathways in osteoblast cell lines
od: Langeveldt, C, i dr.
Izdano: (2002)

The BH3-only protein BIM is upregulated in osteoblasts in response to dexamethasone treatment, growth factor deprivation and anoikis
od: Espina, B, i dr.
Izdano: (2005)

Vanadate sensitive ATPase and phosphatase-activity in guard-cell protoplasts of Commelina
od: Fricker, M, i dr.
Izdano: (1987)

Vanadate sensitive ATPase and phosphatase activity in guard cell protoplasts of Commelina
od: Fricker, M, i dr.
Izdano: (1987)

Sodium Vanadate Treatment as a Shortcut Following Alkaline Phosphatase Cleavage
od: Yu-Yuan Peter Wo, i dr.
Izdano: (1998-09-01)

Manzamenones Inhibit T-Cell Protein Tyrosine Phosphatase
od: Jun'ichi Kobayashi, i dr.
Izdano: (2006-02-01)

Protein Tyrosine Phosphatase Biochemical Inhibition Assays
od: Marek Baranowski, i dr.
Izdano: (2022-09-01)

The identification of transcriptional targets associated with osteoblast apoptosis signaling in response to growth factor withdrawal
od: Liang, M, i dr.
Izdano: (2006)

The Role of MKP-1 in the Anti-Proliferative Effects of Glucocorticoids in Primary Rat Pre-Osteoblasts.
od: Micheline Sanderson, i dr.
Izdano: (2015-01-01)

Lactoferrin protects osteoblasts and osteocytes from apoptosis
od: Locklin, R, i dr.
Izdano: (2009)

Identification of Phomoxanthone A and B as Protein Tyrosine Phosphatase Inhibitors
od: Runlei Yang, i dr.
Izdano: (2020-09-01)

Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
od: Zhendong Song, i dr.
Izdano: (2021-01-01)

The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.
od: Emmanuel Tadjuidje, i dr.
Izdano: (2012-01-01)

The mechanism of allosteric inhibition of protein tyrosine phosphatase 1B.
od: Shuai Li, i dr.
Izdano: (2014-01-01)

Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase
od: Tähtinen Siri, i dr.
Izdano: (2010-01-01)

Activation of Ceramidase and Ceramide Kinase by Vanadate via a Tyrosine Kinase–Mediated Pathway
od: Eiko Tada, i dr.
Izdano: (2010-01-01)

Osteoblast Differentiation on Collagen Scaffold with Immobilized Alkaline Phosphatase
od: F Jafary, i dr.
Izdano: (2017-10-01)

The mode of action of the Protein tyrosine phosphatase 1B inhibitor Ertiprotafib.
od: Ganesan Senthil Kumar, i dr.
Izdano: (2020-01-01)

Crystal structure of the vanadate-inhibited Ca(2+)-ATPase
od: Clausen, J, i dr.
Izdano: (2016)

Chemical inhibition of bacterial protein tyrosine phosphatase suppresses capsule production.
od: Alistair J Standish, i dr.
Izdano: (2012-01-01)

Glucocorticoid transiently upregulates mitochondrial biogenesis in the osteoblast
od: Chien-Ning Hsu, i dr.
Izdano: (2020-01-01)

Protein Tyrosine Phosphatase 1B Inhibitors from the Stems of Akebia quinata
od: Jin-Pyo An, i dr.
Izdano: (2016-08-01)

Role of receptor protein tyrosine phosphatase alpha (RPTPalpha) and tyrosine phosphorylation in the serotonergic inhibition of voltage-dependent potassium channels.
od: Imbrici, P, i dr.
Izdano: (2000)